LAFENDRA
Dead / Abandoned — Abandoned — no statement of use filed (as of 10 Oct 2022)
What this means for you
This application is over — abandoned 10 Oct 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87030250
- Mark type
- Stylized text
- Filed
- 09 May 2016
- Published for opposition
- 14 Jul 2020
- Abandoned
- 10 Oct 2022
- Attorney of record
- Fara S. Sunderji
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders, mood disorders, oppositional defiance disorder, conduct disorder, learning disabilities, autism spectrum disorder, tic disorders, binge eating and obsessive eating disorders, anxiety disorders, substance abuse disorders, depression, psychosis
Owner
- PURDUE PHARMA L.P., STAMFORD, CT, US
- PURDUE PHARMA L.P., STAMFORD, CT, US
- Purdue Pharma, Pickering, Ontario, CA
Prosecution history
- 11 Oct 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 10 Oct 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 12 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Feb 2022 — SOU EXTENSION 3 GRANTED
- 10 Feb 2022 — SOU EXTENSION 3 FILED
- 10 Feb 2022 — SOU TEAS EXTENSION RECEIVED
- 30 Jul 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jul 2021 — SOU EXTENSION 2 GRANTED
- 28 Jul 2021 — SOU EXTENSION 2 FILED
- 28 Jul 2021 — SOU TEAS EXTENSION RECEIVED
- 09 Mar 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Mar 2021 — SOU EXTENSION 1 GRANTED
- 05 Mar 2021 — SOU EXTENSION 1 FILED
- 05 Mar 2021 — SOU TEAS EXTENSION RECEIVED
- 08 Sept 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT